Aspirin, superoxide anions and development of hypertension

Journal of Hypertension

Volumn 22, Issue 4, 2004, Pages 681-682

  Bobik, Alex ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN; CYCLOOXYGENASE 2; SUPEROXIDE;

ANTIINFLAMMATORY ACTIVITY; DRUG EFFECT; EDITORIAL; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART HYPERTROPHY; HEART PROTECTION; HUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SYSTOLIC HYPERTENSION;

EID: 2142702345     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200404000-00006     Document Type: Editorial

References (26)

1. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease-molecular and pathophysiological implications. J Physiol 2003; in press.
2. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20:2175-2183.
3. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 2002; 90:1205-1213.
4. Kalinina N, Agrotis A, Tararak E, Antropova Y, Kanellakis P, Ilyinskaya O, et al. Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2002; 22:2037-2043.
5. Szocs K, Lassegue B, Sorescu D, Hilenski LL, Valppu L, Couse TL, et al. Upregulation of Nox-based NAD(P)H oxidase in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 2002; 22:21-27.
6. Morawietz H, Weber M, Rueckschloss U, Lauer N, Hacker A, Kojda G. Upregulation of vascular NAD(P)H oxidase subunit gp91phox and impairment of the nitric oxide signal transduction pathway in hypertension. Biochem Biophys Res Commun 2001; 285:1130-1135.
7. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, et al. Role of p47phox in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002; 40:511-515.
8. Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 2003; 92:461-468.
9. Dusting GJ, Fennessy P, Yin ZL, Dusting GJ, Fennessy P, Yin ZL, Gurevich V. Nitric oxide in atherosclerosis: vascular protector or villain? Clin Exp Pharmacol Physiol 1998 25:S34-S41.
10. Kitiyakara C, Wilcox CS. Antioxidants for hypertension. Curr Opin Nephrol Hypertens 1998; 7:531-538.
11. Rolla G, Brussino L, Carra R, Garbella E, Bucca C. Hypertension and ascorbic acid. Lancet 2000; 355:1271-1272.
12. Wu R, Laplante M-A, de Champlain J. Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J Hypertens 2004; 22:793-802.
13. Shi X, Ding M, Dong Z, Chen F, Ye J, Wang S, et al. Antioxidant properties of aspirin: characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-kappaB activation and TNF-alpha production. Mol Cell Biochem 1999; 199:93-102.
14. Herman M, Kapiotis S, Hofbauer R, Exner M, Seelos C, Held I, Gmeiner B. Salicylate inhibits LDL oxidation initiated by superoxide/nitric oxide radicals. FEBS Lett 1999; 445:212-214.
15. Sagone AL, Husney RM. Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems. J Immunol 1987; 138:2177-2183.
16. Fiorucci S, Distrutti E, de Lima OM, Romano M, Mencarelli A, Barbanti M, et al. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. FASEB J 2003; 17:1171-1173.
17. Wu R, Lamontagne D, de Champlain J. Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 2002; 105:387-392.
18. Maehara K, Uekawa N, Isobe K. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene. Biochem Biophys Res Commun 2002; 295:187-192.
19. Park YM, Park MY, Suh YL, Park JB. NAD(P)H oxidase inhibitor prevents blood pressure elevation and hypertrophy in aldosterone-infused rats. Biochem Biophys Res Commun 2004; 313:812-817.
20. Nakagami H, Takemotot M, Liao JK. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol 2003; 25:851-859.
21. Mueller C, Baudler S, Welzel H, Bohm M, Nickenig G. Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth. Circulation 2002; 105:2423-2438.
22. Mehta P. Aspirin in the prophylaxis of coronary disease. Curr Opin Cardiol 2002; 17:552-558.
23. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002; 105:1429-1435.
24. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98:2572-2579.
25. Nawarskas JJ, Townsend RR, Cirigliano MD, Spinler SA. Effect of aspirin on blood pressure in hypertensive patients taking losartan. Am J Hypertens 1999; 12:784-789.
26. Hermida RC, Ayala DE, Calvo C, Lopez JE, Fernandez JR, Mojon A, et al. Administration time-dependent effects of aspirin on blood pressure in untreated hypertensive patients. Hypertension 2003; 41:1259-1267.